In the final days of the Biden Administration, the United States Food and Drug Administration (FDA) issued final guidance on Scientific Information on Unapproved Uses (SIUU), Communications From Firms ...
Policy & Medicine offers a daily look at legal, regulatory, and compliance issues affecting the pharmaceutical and device industry. Since its inception in 2008, Policy & Medicine has become one of the ...